Moderna, Inc. (MRNA) stock
MRNANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30537% above fair value
$206.80−8.47 (-3.93%)
Close on Nov 17, 2026Market cap $82.56BP/E –Yield –
Moderna gross margin
Gross margin is gross profit as a percentage of revenue.
Moderna's gross margin for the twelve months ending Jun 30, 2026 was 23.4%. For fiscal 2025 it was 55.3%, against 54.8% the year before. The highest annual figure on record is 100.0% in fiscal 2018.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 55.3% | +0.6 |
| FY2024 | Dec 31, 2024 | 54.8% | +23.3 |
| FY2023 | Dec 31, 2023 | 31.5% | −40.4 |
| FY2022 | Dec 31, 2022 | 71.9% | −13.9 |
| FY2021 | Dec 31, 2021 | 85.8% | −13.2 |
| FY2020 | Dec 31, 2020 | 99.0% | −1.0 |
| FY2019 | Dec 31, 2019 | 100.0% | +0.0 |
| FY2018 | Dec 31, 2018 | 100.0% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 35.9% | +19.7 |
| Q1 FY2026 | Mar 31, 2026 | -145.5% | −162.2 |
| Q4 FY2025 | Dec 31, 2025 | 33.3% | +9.8 |
| Q3 FY2025 | Sep 30, 2025 | 79.6% | +7.2 |
| Q2 FY2025 | Jun 30, 2025 | 16.2% | −36.1 |
| Q1 FY2025 | Mar 31, 2025 | 16.7% | −25.8 |
| Q4 FY2024 | Dec 31, 2024 | 23.5% | −43.5 |
| Q3 FY2024 | Sep 30, 2024 | 72.4% | +94.8 |
| Q2 FY2024 | Jun 30, 2024 | 52.3% | +164.8 |
| Q1 FY2024 | Mar 31, 2024 | 42.5% | −15.0 |
| Q4 FY2023 | Dec 31, 2023 | 67.0% | +4.7 |
| Q3 FY2023 | Sep 30, 2023 | -22.4% | −89.7 |
| Q2 FY2023 | Jun 30, 2023 | -112.5% | −183.4 |
| Q1 FY2023 | Mar 31, 2023 | 57.5% | −25.8 |
| Q4 FY2022 | Dec 31, 2022 | 62.3% | −24.5 |
| Q3 FY2022 | Sep 30, 2022 | 67.3% | −18.2 |
| Q2 FY2022 | Jun 30, 2022 | 70.9% | −11.9 |
| Q1 FY2022 | Mar 31, 2022 | 83.2% | −6.8 |
| Q4 FY2021 | Dec 31, 2021 | 86.8% | −11.8 |
| Q3 FY2021 | Sep 30, 2021 | 85.5% | −14.5 |
| Q2 FY2021 | Jun 30, 2021 | 82.8% | −17.2 |
| Q1 FY2021 | Mar 31, 2021 | 90.0% | −10.0 |
| Q4 FY2020 | Dec 31, 2020 | 98.6% | – |
| Q3 FY2020 | Sep 30, 2020 | 100.0% | – |
| Q2 FY2020 | Jun 30, 2020 | 100.0% | – |
| Q1 FY2020 | Mar 31, 2020 | 100.0% | – |
See a number that looks wrong?